Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Reexamination Certificate
2005-10-04
2005-10-04
Raymond, Richard L. (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C514S252170
Reexamination Certificate
active
06951937
ABSTRACT:
The present invention provides nitrogen-containing heterocyclic compounds and pharmaceutically acceptable salts thereof and a process for making thereof. The compounds have inhibitory activity on the phosphorylation of kinases, which inhibits the activity of such kinases. The invention also provides intermediate compounds useful in the process, as well as final products produced by the process, and salts or prodrugs thereof. The invention further provides a method of inhibiting kinases and treating disease states in a mammal by inhibiting the phosphorylation of kinases comprising administering an effective amount of a compound according to the invention to a patient in need thereof.
REFERENCES:
patent: 0 882 717 (1998-12-01), None
patent: 1 067 123 (2001-01-01), None
patent: 5-208911 (1993-08-01), None
patent: 6-87834 (1994-03-01), None
patent: 06-247942 (1994-09-01), None
patent: 11-80131 (1999-03-01), None
patent: WO 92/20642 (1992-11-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 98/14431 (1998-09-01), None
patent: WO 00/47212 (2000-08-01), None
patent: WO 01/004102 (2001-01-01), None
patent: 02/16360 (2002-02-01), None
patent: 02/16362 (2002-02-01), None
patent: 6706512 (1967-10-01), None
Agrawal, V. et al., “Antiparasitic agents: Part VI—synthesis of 7-chloro-4-(4-substituted-phenylamino)- & 7-chloro-4-(4-substituted-piperazin-1-yl)quinolines as potential antiparasitic agents” Indian Journal of Chemistry 26B:550-555 (1987).
Anderson, K. et al., “Oxadiazoles as bioisosteric transformations of carboxylic functionalities” Eur. J. Med. Chem. 31:417-425 (1996).
Chen, S. et al., “Putative benzodiazepine partial agonists demonstrate receptor heterogeneity” Pharmacology Biochemistry and Behavior 53(1):87-97 (1996).
Kovalenko, M. et al., “Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation” Cancer Research 54:6106-6114 (1994).
Patent Abstracts of Japan vol. 8, No. 3, Jan. 7, 1984 & JP 58 172379 A (Showa Denko KK), Oct. 11, 1983 (Abstract).
Patent Abstracts of Japan vol. 9, No. 271, Oct. 29, 1985 & JP 60 120872 A (Kyowa Hakko Kogyo Co., Ltd.), Jun. 28, 1985 (Abstract).
Patent Abstracts of Japan vol. 18, No. 639, Dec. 6, 1994 & JP 06 247942 A (Kyowa Hakko Kogyo Co., Ltd.), Sep. 6, 1994 (Abstract).
Abstracts of the 116th Annual Meeting of the Pharmaceutical Society of Japan, Kanazawa, 2:275; 29(C2):15-21 (1996).
Kanter James
Pandey Anjali
Robinson James
Scarborough Robert M.
Millennium Pharmaceuticals Inc.
Raymond Richard L.
Townsend and Townsend / and Crew LLP
Truong Tamthom N.
LandOfFree
Nitrogenous heterocyclic compounds and process for making... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nitrogenous heterocyclic compounds and process for making..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitrogenous heterocyclic compounds and process for making... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3461468